LUPINPharmaceuticals
Lupin Ltd — Cash Flow Statement
₹2313.90
-0.66%
Lupin Ltd Cash Flow Statement (Annual)
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Free Cash Flow | 1.32K Cr | 2.72K Cr | 397.62 Cr | -537.77 Cr | — |
| Repayment Of Debt | 0.00 | -27.51 Cr | -113.49 Cr | -16.13 Cr | — |
| Issuance Of Debt | 1.22K Cr | 0.00 | 0.00 | 141.86 Cr | — |
| Issuance Of Capital Stock | 39.86 Cr | 14.55 Cr | 1.94 Cr | 16.08 Cr | — |
| Capital Expenditure | -1.68K Cr | -928.90 Cr | -1.50K Cr | -905.08 Cr | — |
| End Cash Position | 1.54K Cr | 983.76 Cr | 1.26K Cr | 1.01K Cr | — |
| Beginning Cash Position | 983.76 Cr | 1.23K Cr | 991.37 Cr | 926.22 Cr | — |
| Changes In Cash | 559.93 Cr | -248.05 Cr | 273.22 Cr | 87.22 Cr | — |
| Financing Cash Flow | 1.73K Cr | -2.18K Cr | -337.25 Cr | -1.57K Cr | — |
| Interest Paid Cff | -255.14 Cr | -282.91 Cr | -226.68 Cr | -123.99 Cr | — |
| Cash Dividends Paid | -365.31 Cr | -182.80 Cr | -182.50 Cr | -295.09 Cr | — |
| Common Stock Dividend Paid | -365.31 Cr | -182.80 Cr | -182.50 Cr | — | — |
| Net Common Stock Issuance | 39.86 Cr | 14.55 Cr | 1.94 Cr | 16.08 Cr | — |
| Common Stock Issuance | 39.86 Cr | 14.55 Cr | 1.94 Cr | 16.08 Cr | — |
| Net Issuance Payments Of Debt | 2.43K Cr | -1.62K Cr | 172.81 Cr | -1.08K Cr | — |
| Net Short Term Debt Issuance | 1.21K Cr | -1.59K Cr | 286.30 Cr | -1.20K Cr | — |
| Net Long Term Debt Issuance | 1.22K Cr | -27.51 Cr | -113.49 Cr | 125.73 Cr | — |
| Long Term Debt Payments | 0.00 | -27.51 Cr | -113.49 Cr | -16.13 Cr | — |
| Long Term Debt Issuance | 1.22K Cr | 0.00 | 0.00 | 141.86 Cr | — |
| Investing Cash Flow | -4.17K Cr | -1.71K Cr | -1.29K Cr | 1.29K Cr | — |
| Net Other Investing Changes | -2.57K Cr | -157.94 Cr | 37.14 Cr | 715.07 Cr | — |
| Interest Received Cfi | 129.85 Cr | 46.24 Cr | 32.43 Cr | 32.81 Cr | — |
| Net Investment Purchase And Sale | -32.40 Cr | -537.36 Cr | 432.89 Cr | 2.30K Cr | — |
| Sale Of Investment | 17.02K Cr | 10.59K Cr | 12.26K Cr | 13.65K Cr | — |
| Purchase Of Investment | -17.05K Cr | -11.13K Cr | -11.82K Cr | -11.35K Cr | — |
| Net Business Purchase And Sale | -46.26 Cr | -146.50 Cr | -291.00 Cr | -146.80 Cr | — |
| Purchase Of Business | -46.26 Cr | -146.50 Cr | -291.00 Cr | -146.80 Cr | — |
| Net PPE Purchase And Sale | -1.65K Cr | -916.64 Cr | -1.46K Cr | 7.09 Cr | — |
| Sale Of PPE | 29.35 Cr | 12.26 Cr | 38.53 Cr | 7.09 Cr | — |
| Purchase Of PPE | -1.68K Cr | -928.90 Cr | -1.50K Cr | — | — |
| Operating Cash Flow | 3.00K Cr | 3.65K Cr | 1.90K Cr | 367.31 Cr | — |
| Taxes Refund Paid | -906.04 Cr | -326.05 Cr | -243.18 Cr | 46.88 Cr | — |
| Change In Working Capital | -1.41K Cr | 85.51 Cr | 326.52 Cr | -15.04 Cr | — |
| Change In Other Current Liabilities | -172.64 Cr | 368.73 Cr | 190.82 Cr | 272.11 Cr | — |
| Change In Other Current Assets | 83.15 Cr | -21.06 Cr | -159.92 Cr | -318.28 Cr | — |
| Change In Payable | 1.12 Cr | 418.80 Cr | 216.81 Cr | 234.16 Cr | — |
| Change In Inventory | -541.24 Cr | -440.15 Cr | 195.44 Cr | -499.33 Cr | — |
| Change In Receivables | -780.93 Cr | -240.81 Cr | -147.28 Cr | 278.05 Cr | — |
| Other Non Cash Items | 158.89 Cr | 228.02 Cr | 242.18 Cr | 46.77 Cr | — |
| Stock Based Compensation | 42.25 Cr | 38.33 Cr | 40.76 Cr | 51.39 Cr | — |
| Provisionand Write Offof Assets | 12.08 Cr | 65.29 Cr | 11.53 Cr | -3.58 Cr | — |
| Depreciation And Amortization | 1.17K Cr | 995.56 Cr | 880.69 Cr | 1.66K Cr | — |
| Depreciation | 1.17K Cr | 679.85 Cr | 880.69 Cr | 1.66K Cr | — |
| Gain Loss On Investment Securities | -46.62 Cr | -39.84 Cr | -26.31 Cr | -7.57 Cr | — |
| Net Foreign Currency Exchange Gain Loss | -38.24 Cr | -21.00 Cr | -33.89 Cr | -45.23 Cr | — |
| Gain Loss On Sale Of PPE | -0.28 Cr | -1.17 Cr | -20.98 Cr | 2.93 Cr | — |
| Net Income From Continuing Operations | 4.01K Cr | 2.42K Cr | 716.49 Cr | -1.37K Cr | — |
| Amortization Cash Flow | — | 315.71 Cr | — | — | — |
| Capital Expenditure Reported | — | — | -1.50K Cr | -905.08 Cr | -677.62 Cr |
| Dividends Received Cfi | — | — | — | — | 0.00 |
| Sale Of Business | — | — | — | — | 0.00 |
| Gain Loss On Sale Of Business | — | — | — | — | 0.00 |
All figures in ₹ Crores. Source: NSE/BSE filings via Bull Run.
More on Lupin Ltd
Data from NSE/BSE public filings. Educational purposes only. Bull Run is not SEBI-registered. Not investment advice.